Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association

K Musunuru, RE Hershberger, SM Day… - Circulation: Genomic …, 2020 - Am Heart Assoc
Advances in human genetics are improving the understanding of a variety of inherited
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular …

[HTML][HTML] Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials

PG Carlier, B Marty, O Scheidegger… - Journal of …, 2016 - content.iospress.com
Recent years have seen tremendous progress towards therapy of many previously incurable
neuromuscular diseases. This new context has acted as a driving force for the development …

Familial dysautonomia: History, genotype, phenotype and translational research

L Norcliffe-Kaufmann, SA Slaugenhaupt… - Progress in …, 2017 - Elsevier
Familial dysautonomia (FD) is a rare neurological disorder caused by a splice mutation in
the IKBKAP gene. The mutation arose in the 1500s within the small Jewish founder …

Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy

JN Robinson-Hamm, CA Gersbach - Human genetics, 2016 - Springer
Duchenne muscular dystrophy is one of the most common inherited genetic diseases and is
caused by mutations to the DMD gene that encodes the dystrophin protein. Recent …

Genetics and emerging treatments for Duchenne and Becker muscular dystrophy

N Wein, L Alfano, KM Flanigan - Pediatric Clinics, 2015 - pediatric.theclinics.com
Duchenne and Becker muscular dystrophy (DMD and BMD) are related disorders that occur
because of mutations in the DMD gene, encoding the dystrophin protein. DMD is more …

[HTML][HTML] Gene therapy for the nervous system: challenges and new strategies

CA Maguire, SH Ramirez, SF Merkel, M Sena-Esteves… - …, 2014 - Elsevier
Current clinical treatments for central nervous system (CNS) diseases, such as Parkinson's
disease and glioblastoma do not halt disease progression and have significant treatment …

Correction of a cystic fibrosis splicing mutation by antisense oligonucleotides

S Igreja, LA Clarke, HM Botelho, L Marques… - Human …, 2016 - Wiley Online Library
Cystic fibrosis (CF), the most common life‐threatening genetic disease in Caucasians, is
caused by∼ 2,000 different mutations in the CF transmembrane conductance regulator …

Duchenne muscular dystrophy: current cell therapies

D Sienkiewicz, W Kulak… - Therapeutic …, 2015 - journals.sagepub.com
Duchenne muscular dystrophy is a genetically determined X-linked disease and the most
common, progressive pediatric muscle disorder. For decades, research has been conducted …

Enhancing literacy in cardiovascular genetics: a scientific statement from the American Heart Association

S Mital, K Musunuru, V Garg, MW Russell… - Circulation …, 2016 - Am Heart Assoc
Advances in genomics are enhancing our understanding of the genetic basis of
cardiovascular diseases, both congenital and acquired, and stroke. These advances include …

Nusinersen in the treatment of spinal muscular atrophy

K Goodkey, T Aslesh, R Maruyama… - Exon skipping and …, 2018 - Springer
Spinal muscular atrophy (SMA) is one of the most common genetic causes of infantile death
arising due to mutations in the SMN1 gene and the subsequent loss of motor neurons. With …